Nordic Secondary Fund is pleased to announce that we have acquired a stake in Norlase, an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease.
Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.
With the investment in Norlase Nordic Secondary Fund I’s portfolio now consists of: Klarna, OnRobot, ROOM, Click & Grow, MapsPeople, GoMore, Varjo and Norlase.
Learn more about Norlase on their website: Norlase.com
